For those of you interested in weight loss surgery, I thought you might be interested in some information I recently received about a study that is recruiting eligible participants for a new type of weight loss surgery.
The information provided follows:
Australian weight loss clinics in new global study of unique obesity therapy.
The Institute of Weight Control in Sydney and the Adelaide Bariatric Centre have been chosen as clinical research sites to evaluate the safety and effectiveness of a new investigational device providing VBLOC™ Therapy for the treatment of obesity.
VBLOC™ Therapy involves a surgical procedure using an investigational device that does not alter the stomach’s anatomy. Instead, laparoscopically-implanted electrodes have been designed to block the vagus nerve and the signals carried between the brain and the digestive system that control sensations of hunger, satisfaction and fullness.
The international study involves 15 research sites and aims to recruit 300 patients by June 2008. Sydney and Adelaide are the only two sites outside of the USA.
According to Professor Jim Toouli from the Adelaide Bariatric Centre, who is the Professor of Digestive Surgery at Flinders Medical Centre, the new therapy holds great promise for the future treatment of people who are morbidly obese. “Both of the Centres in Australia have run small pilot studies with the therapy in the past which have been very encouraging. We clearly need to test its effectiveness via a large, international, double-blinded trial. So it’s very exciting to be part of this study,” said Professor Toouli.
Potential participants may include men and women between the ages of 18 and 65 who have a BMI (body mass index) between 35 and 45. Those with a BMI of less than 40 must also have been diagnosed with sleep apnea, high cholesterol, obesity-related cardiomyopathy or hypertension. In addition to the device, participants will receive education and advice on diet, exercise and behaviour modification.
Dr Roy Brancatisano, Head Surgeon at the Institute of Weight Control in Sydney, said it was a great privilege for the Australian sites to be invited to participate in the study and underpinned the quality of the services being offered at each Centre. “We’re very proud of the quality of the clinical services and public health research being conducted at each of these sites and very pleased to get acknowledgement via invitation into these international research programs,” said Dr Brancatisano.
Patients interested in participating in the clinical research study may call the information line 1300 798 987 for more information and to determine eligibility.